Major pharmaceutical company acquires catnip repellent IP by 2028

The commercial viability of catnip-based repellents will attract a top-tier pharma or agrochemical firm to acquire or license the technology. This would accelerate scaling and integration into existing product lines.

legal · Prediction Market

Implied probability (Yes)

60%

Closes

2028-06-30

More legal markets

• Will Congress hold hearings about Epstein Black Book and the Epstein case? — 63% Yes
• Will new charges be filed related to Alan Dershowitz by September 2026? — 31% Yes
• Will Alan Dershowitz reach a settlement in Epstein-related lawsuits by the next 6 months? — 62% Yes
• Will Epstein Island be featured in a major documentary about the Epstein case? — 33% Yes
• Will Epstein 2008 Plea Deal make public statements about Epstein connections by end of 2026? — 19% Yes
• Will Alexander Acosta Plea Deal reach a settlement in Epstein-related lawsuits by 2026? — 57% Yes
• Will Epstein 2008 Plea Deal be subpoenaed in connection with Epstein case by end of 2026? — 35% Yes
• Will new charges be filed related to Little Saint James by March 2026? — 93% Yes

Browse all legal markets →